Jian-Chao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian-Chao Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Kai Song
Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Chinese Medicine, Zhengzhou 450046, China
2 shared publications - Weisheng Feng
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, P. R. China
2 shared publications - Xiaoke Zheng
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China
2 shared publications - Yan-Li Zhang
Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, Henan, China
2 shared publications - Hai-Xue Kuang
College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China
1 shared publication - Meng Li
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication
Latest Publications
- Open Access
Four New Monoterpenoid Glycosides from the Flower Buds of Magnolia biondii
Four new monoterpenoid glycosides 1–4, named magnoliaterpenoid A–D, were isolated from a 50% aqueous acetone extract of flower buds of Magnolia biondii, along with one known compound, (1′R,3′S,5′R,8′S,2Z,4E)-dihydrophaseic acid 3-O-β-d-glucopyranoside (5). Their structures and relative configuration were identified by extensive spectroscopic analysis (IR, UV, MS, 1D and 2D NMR). The aglycones of these four new compounds possess seven-membered rings systems, which are very rare. A plausible biosynthetic route for the four new compounds was proposed via the biogenetic isoprene rule. Compounds 1, 2, 3, and 4 showed no antimicrobial activity at the concentration range of 1.95–250 µg/mL.
Open AccessFour New Monoterpenoid Glycosides from the Flower Buds of Magnolia biondii
Four new monoterpenoid glycosides 1–4, named magnoliaterpenoid A–D, were isolated from a 50% aqueous acetone extract of flower buds of Magnolia biondii, along with one known compound, (1′R,3′S,5′R,8′S,2Z,4E)-dihydrophaseic acid 3-O-β-d-glucopyranoside (5). Their structures and relative configuration were identified by extensive spectroscopic analysis (IR, UV, MS, 1D and 2D NMR). The aglycones of these four new compounds possess seven-membered rings systems, which are very rare. A plausible biosynthetic route for the four new compounds was proposed via the biogenetic isoprene rule. Compounds 1, 2, 3, and 4 showed no antimicrobial activity at the concentration range of 1.95–250 µg/mL.
- Open Access
A New Ionone Glycoside and Three New Rhemaneolignans from the Roots of Rehmannia glutinosa
A new ionone glycoside, frehmaglutoside I (1), and three new rhemaneolignans A–C (2–4) were isolated from the 95% EtOH extract of the roots of Rehmannia glutinosa. Their structures were determined by extensive spectroscopic (UV, IR, HR-ESI-MS, 1D and 2D NMR) analyses. In addition, these compounds were evaluated for their protective effects on cardiocytes impaired by doxorubicin in H9c2 cells. Among them, compounds 1–3 exhibited protective effects against DOX-induced cardiotoxicity.
Open AccessA New Ionone Glycoside and Three New Rhemaneolignans from the Roots of Rehmannia glutinosa
A new ionone glycoside, frehmaglutoside I (1), and three new rhemaneolignans A–C (2–4) were isolated from the 95% EtOH extract of the roots of Rehmannia glutinosa. Their structures were determined by extensive spectroscopic (UV, IR, HR-ESI-MS, 1D and 2D NMR) analyses. In addition, these compounds were evaluated for their protective effects on cardiocytes impaired by doxorubicin in H9c2 cells. Among them, compounds 1–3 exhibited protective effects against DOX-induced cardiotoxicity.